Концепция эндофенотипа: новый подход к изучению патогенеза аффективных расстройств (аналитический обзор). Часть 2
Рекомендуемое оформление библиографической ссылки:
Вазагаева Т.И., Ахапкин Р.В. Концепция эндофенотипа: новый подход к изучению патогенеза аффективных расстройств (аналитический обзор). Часть 2 // Российский психиатрический журнал. 2013. №4. С. 37-48.
В статье проводится систематический анализ результатов нейробиологических исследований, направленных на поиск кандидатов-эндофенотипов при аффективных расстройствах, занимающих промежуточное положение между генетическими факторами и клиническими проявлениями заболевания. Описываются нейровизуализационные (структурные и функциональные) и нейрохимические нарушения, выявляемые при аффективной патологии, такие как гиперинтенсивность белого вещества мозга, повышенная активация миндалины и орбитофронтальной коры, патологические изменения нейротрофических факторов и концентраций различных нейрохимических субстратов и нейротрансмиттеров в определенных областях мозга и др., наиболее специфично и доказательно отражающие этиопатогенетические механизмы развития болезненного процесса.
1. Adler C.M., Holland S.K., Schmithorst V. et al. Changes in neuronal activation in patients with bipolar disorder during performance of a working memory task // Bipolar Disord. - 2004. - Vol. 6. - P. 540-549. 2. Agid R., Levin T., Gomori J.M., Lerer B. et al. T2-weighted image hyperintensities in major depression: focus on the basal ganglia // Int. J. Neuropsychopharmacol. - 2003. - Vol. 6, N 3. - P. 215-224. 3. Altshuler L., Bookheimer S., Proenza M.A. et al. Increased amygdala activation during mania: a functional magnetic resonance imaging study // Am. J. Psychiatry. - 2005. - Vol. 162. - P. 1211-1213. 4. Andreasen N.C., Swayze V.I.I., Flaum M. et al. Ventricular abnormalities in affective disorder: clinical and demographic correlates // Am. J. Psychiatry. - 1990. - Vol. 147, N 7. - P. 893-900. 5. Aydemir C., Yalcin E.S., Aksaray S. et al. Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women // Prog. Neuropsychopharmacol. Biol. Psychiatry. - 2006. - Vol. 30, N 7. - P. 1256-1260. 6. Baarе W.F., Hulshoff Pol H.E., Boomsma D.I. et al. Quantitative genetic modeling of variation in human brain morphology //Cereb. Cortex. - 2001. - Vol. 11, N 9. - P. 816-824. 7. Bearden C.E., Soares J.C., Klunder A.D. et al. Three dimensional mapping of hippocampal anatomy in adolescents with bipolar disorder // J. Am. Acad. Child Adolesc. Psychiatry. - 2008. - Vol. 47. - P. 515-525. 8. Bearden C.E., Thompson P.M., Dalwani M. et al. Greater cortical gray matter density in lithium-treated patients with bipolar disorder // Biol. Psychiatry. - 2007. - Vol. 62, N 1. - P. 7-16. 9. Benedetti F., Absinta M., Rocca M.A. et al. Tract-specific white matter structural disruption in patients with bipolar disorder // Bipolar Disord. - 2011. - Vol. 13, N 4. - P. 414-24. 10. Berman R.M., Narasimhan M., Miller H.L. et al. Transient depressive relapse induced by catecholamine depletion: potential phenotypic vulnerability marker? // Arch. Gen. Psychiatry. - 1999. - Vol. 56, N 5. - P. 395-403. 11. Bhagwagar Z., Wylezinska M., Jezzard P. et al. Reduction in occipital cortex gamma-amin-obutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects // Biol. Psychiatry. - 2007. - Vol. 61. - P. 806-812. 12. Blumberg H.P., Kaufman J., Martin A. et al. Amygdala and hippocampal volumes in adolescents and adults with bipolar disorder // Arch. Gen. Psychiatry. - 2003. - Vol. 60. - P. 1201-1208. 13. Blumberg H.P., Wang F., Chepenik L.G. et al. Influence of vascular endothelial growth factor variation on human hippocampus morphology // Biol. Psychiatry. - 2008. - Vol. 64, N 10. - P. 901-903. 14. Borgwardt S., Fusar-Poli P. White matter pathology - an endophenotype for bipolar disorder? // BMC Psychiatry. - 2012. - Vol. 12, N 1. - P. 138. 15. Botteron K.N., Raichle M.E., Heath A.C. et al. An epidemiological twin study of prefrontal neuromorphometry in early onset depression // Biol. Psychiatry. - 1999. - Vol. 45. - P. 59. 16. Bremner J.D., Vythilingam M., Vermetten E. et al. Reduced volume of orbitofrontal cortex in major depression // Biol. Psychiatry. -2002. - Vol. 51, N 4. - P. 273-279. 17. Bueller J.A., Aftab M., Sen S. et al. BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects // Biol. Psychiatry. - 2006. - Vol. 59, N 9. - P. 812-815. 18. Caetano S.C., Hatch J.P., Brambilla P. et al. Anatomical MRI study of hippocampus and amygdala in patients with current and remitted major depression // Psychiatry Res. - 2004. - Vol. 132, N 2. - P. 141-147. 19. Caetano S.C., Sassi R., Brambilla P. et al. MRI study of thalamic volumes in bipolar and unipolar patients and healthy individuals // Psychiatry Res. - 2001. - Vol. 108, N 3. - P. 161-168. 20. Carter C.J. EIF2B and oligodendrocyte survival: where nature and nurture meet in bipolar disorder and schizophrenia? // Schizophr. Bull. - 2007. - Vol. 33, N 6. - P. 1343-1353. 21. Carter C.J. Multiple genes and factors associated with bipolar disorder converge on growth factor and stress activated kinase pathways controlling translation initiation: implications for oligodendrocyte viability // Neurochem. Int. - 2007. - Vol. 50, N 3. - P. 461- 490. 22. Caspi A., Sugden K., Moffitt T.E. et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene // Science. - 2003. - Vol. 301. - P. 386-389. 23. Cecil K.M., DelBello M.P., Sellars M.C. et al. Proton magnetic resonance spectroscopy of the frontal lobe and cerebellar vermis in children with a mood disorder and a familial risk for bipolar disorders // J. Child Adolesc. Psychopharmacol. - 2003. - Vol. 13, N 4. - P. 545-555. 24. Chang K., Barnea-Goraly N., Karchemskiy A. et al. Cortical magnetic resonance imaging findings in familial pediatric bipolar disorder // Biol. Psychiatry. - 2005. - Vol. 58, N 3. - P. 197-203. 25. Chang K., Karchemskiy A., Barnea-Goraly N. et al. Reduced amygdalar gray matter volume in familial pediatric bipolar disorder // J. Am. Acad. Child Adolesc. Psychiatry. - 2005. - Vol. 44. - P. 565-573. 26. Charney D.S. Monoamine dysfunction and the pathophysiology and treatment of depression // J. Clin. Psychiatry. - 1998. - Vol. 59, N 14. - P. 11-14. 27. Charney D.S., Drevets W.C. The neurobiological basis of anxiety disorders // Neuropsychopharmacology: The Fifth Generation of Progress / Eds K.L. Davis, D.S. Charney, J.T. Coyle, C.B. Nemeroff. - Philadelphia, PA: Lippincott Williams and Wilkins, 2002. - P. 901-930. 28. Charney D.S., Menkes D.B., Heninger G.R. Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression // Arch. Gen. Psychiatry. - 1981. - Vol. 38, N 10. - P. 1160-1180. 29. Chen H.H., Nicoletti M.A., Hatch J.P. et al. Abnormal left superior temporal gyrus volumes in children and adolescents with bipolar disorder: a magnetic resonance imaging study // Neurosci. Lett. - 2004. - Vol. 363. - P. 65-68. 30. Chen B.K., Sassi R., Axelson D. et al. Cross-sectional study of abnormal amygdale development in adolescents and young adults with bipolar disorder // Biol. Psychiatry. - 2004. - Vol. 56. - P. 399-405. 31. Coffey C.E., Wilkinson W.E., Weiner R.D. et al. Quantitative cerebral anatomy in depression. A controlled magnetic resonance imaging study // Arch. Gen. Psychiatry. - 1993. - Vol. 50, N 1. - P. 7-16. 32. Coppen A., Eccleston E.G., Peet M. Total and free tryptophan concentration in the plasma of depressive patients //Lancet. - 1973. - Vol. 7820, N 2. - P. 60-63. 33. Craddock N., Jones I. Genetics of bipolar disorder // J. Med. Genet. - 1999. - Vol. 36, N 8. - P. 585-594. 34. Dager S.R., Friedman S.D., Parow A. et al. Brain metabolic alterations in medication-free patients with bipolar disorder // Arch. Gen. Psychiatry. - 2004. - Vol. 61. - P. 450-458. 35. Dasari M., Friedman L., Jesberger J. et al. A magnetic resonance imaging study of thalamic area in adolescent patients with either schizophrenia or bipolar disorder as compared to healthy controls // Psychiatry Res. - 1999. - Vol. 91. - P. 155-162. 36. Davis K.A., Kwon A., Cardenas V.A. et al. Decreased cortical gray and cerebral white matter in male patients with familial bipolar I disorder // J. Affect. Disord. - 2004. - Vol. 82, N 3. - P. 475-485. 37. DelBello M.P., Zimmerman M.E., Mills N.P. et al. Magnetic resonance imaging analysis of amygdala and other subcortical brain regions in adolescents with bipolar disorder // Bipolar Disord. - 2004. - N 6. - P. 43-52. 38. Delgado P.L., Price L.H., Miller H.L. et al. Serotonin and the neurobiology of depression. Effects of tryptophan depletion in drug-free depressed patients // Arch. Gen. Psychiatry. - 1994. - Vol. 51, N 11. - P. 865-874. 39. De Peri L., Crescini A., Deste G. et al. Brain structural abnormalities at the onset of schizophrenia and bipolar disorder: a meta-analysis of controlled magnetic resonance imaging studies // Curr. Pharm. Des. - 2012. - Vol. 18, N 4. - P. 486-494. 40. Dickstein D.P., Milham M.P., Nugent A.C. et al. Frontotemporal alterations in pediatric bipolar disorder: results of a voxelbased morphometry study // Arch. Gen. Psychiatry. - 2005. - Vol. 62, N 7. - P. 734-741. 41. Drevets W.C., Price J.L., Simpson J.R. Jr. et al. Subgenual prefrontal cortex abnormalities in mood disorders // Nature. - 1997. - Vol. 386. - P. 824-827. 42. Drevets W.C., Videen T.O., Price J.L. et al. A functional anatomical study of unipolar depression // J. Neurosci. - 1992. - Vol. 12, N 9. - P. 3628-3641. 43. Dubin M.J., Weissman M.M., Xu D. et al. Identification of a circuit-based endophenotype for familial depression // Psychiatry Res. - 2012. - Vol. 201, N 3. - P. 175-181. 44. Duman R.S., Heninger G.R., Nestler E.J. A molecular and cellular theory of depression // Arch. Gen. Psychiatry. - 1997. - Vol. 54, N 7. - P. 597-606. 45. Duncan L.E., Hutchison K.E., Carey G. et al. Variation in brainderived neurotrophic factor (BDNF) gene is associated with symptoms of depression // J. Affect. Disord. - 2009. - Vol. 115, N 1-2. - P. 215-219. 46. Elkis H., Friedman L., Wise A. et al. Meta-analyses of studies of ventricular enlargement and cortical sulcal prominence in mood disorders. Comparisons with controls or patients with schizophrenia // Arch. Gen. Psychiatry. - 1995. - Vol. 52, N 9. - P. 735-746. 47. Filipek P.A., Semrud-Clikeman M., Steingard R.J. et al. Volumetric MRI analysis comparing subjects having attention-defi cit hyperactivity disorder with normal controls // Neurology. - 1997. - Vol. 48. - P. 589-601. 48. Frazier J.A., Chiu S., Breeze J.L. et al. Structural brain magnetic resonance imaging of limbic and thalamic volumes in pediatric bipolar disorder // Am. J. Psychiatry. - 2005. - Vol. 162. - P. 1256-1265. 49. Frey B.N., Stanley J.A., Nery F.G. et al. Abnormal cellular energy and phospholipid metabolism in the left dorsolateral prefrontal cortex of medication-free individuals with bipolar disorder: an in vivo 1H MRS study // Bipolar Disord. - 2007. - Vol. 9, N 1. - P. 119-127. 50. Frodl T., Meisenzahl E.M., Zetzsche T. et al. Larger amygdala volumes in first depressive episode as compared to recurrent major depression and healthy control subjects // Biol. Psychiatry. - 2003. - Vol. 53, N 4. - P. 338-344. 51. Frye M.A., Watzl J., Banakar S. et al. Increased anterior cingulate/medial prefrontal cortical glutamate and creatine in bipolar depression // Neuropsychopharmacology. - 2007. - Vol. 32. - P. 2490-2499. 52. Glahn D.C., Curran J.E., Winkler A.M. et al. High dimensional endophenotype ranking in the search for major depression risk genes // Biol. Psychiatry. - 2012. - Vol. 71, N 1. - P. 6-14. 53. Gonul A.S., Akdeniz F., Taneli F. et al. Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients // Eur. Arch. Psychiatry Clin. Neurosci. - 2005. - Vol. 255, N 6. - P. 381-386. 54. Gratacos M., Soria V., Urretavizcaya M. et al. A brain-derived neurotrophic factor (BDNF) haplotype is associated with antidepressant treatment outcome in mood disorders // Pharmacogenomics J. - 2008. - Vol. 8, N 2. - P. 101-112. 55. Haldane M., Frangou S. New insights help define the pathophysiology of bipolar affective disorder: neuroimaging and neuropathology findings // Prog. Neuropsychopharmacol. Biol. Psychiatry. - 2004. - Vol. 28, N 6. - P. 943-960. 56. Hamakawa H., Kato T., Murashita J.et al. Quantitative proton magnetic resonance spectroscopy of the basal ganglia in patients with affective disorders // Eur. Arch. Psychiatry Clin. Neurosci. - 1998. - Vol. 248. - P. 53-58. 57. Hasler G., Drevets W.C., Manji H.K. et al.. Discovering endophenotypes for major depression // Neuropsychopharmacology. - 2004. - Vol. 29. - P. 1765-1781. 58. Hasler G., Northoff G. Discovering imaging endophenotypes for major depression // Mol. Psychiatry. - 2011. - Vol. 16, N 6. - P. 604-619. 59. Hoge E.A., Friedman L., Schulz S.C. Meta-analysis of brain size in bipolar disorder // Schizophr. Res. - 1999. - Vol. 37, N 2. - P. 177-181. 60. Husain M.M., McDonald W.M., Doraiswamy P.M. et al. A magnetic resonance imaging study of putamen nuclei in major depression // Psychiatry Res. - 1991. - Vol. 40, N 2. - P. 95-99. 61. Karege F., Perret G., Bondolfi G. et al. Decreased serum brain-derived neurotrophic factor levels in major depressed patients // Psychiatry Res. - 2002. - Vol. 109, N 2. - P. 143-148. 62. Kempton M.J., Geddes J.R., Ettinger U. et al. Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder // Arch. Gen. Psychiatry. - 2008. - Vol. 65, N 9. - P. 1017-1032. 63. Kempton M.J., Salvador Z., Munafo M.R. et al. Structural neuroimaging studies in major depressive disorder. Metaanalysis and comparison with bipolar disorder // Arch. Gen. Psychiatry. - 2011. - Vol. 68, N 7. - P. 675-690. 64. Kieseppa T., van Erp T.G., Haukka J. et al. Reduced left hemispheric white matter volume in twins with bipolar I disorder // Biol. Psychiatry. - 2003. - Vol. 54, N 9. - P. 896-905. 65. Klaassen T., Riedel W.J., Deutz N.E. et al. Mood congruent memory bias induced by tryptophan depletion // Psychol. Med. - 2002. - Vol. 32, N 1. - P. 167-172. 66. Koolschijn P.C., van Haren N.E., Lensvelt-Mulders G.J. et al. Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies // Hum. Brain Mapp. - 2009. - Vol. 30, N 11. - P. 3719-3735. 67. Kraft J.B., Slager S.L., McGrath P.J. et al. Sequence analysis of the serotonin transporter and associations with antidepressant response // Biol. Psychiatry. - 2005. - Vol. 58, N 5. - P. 374-381. 68. Krishnan K.R., McDonald W.M., Escalona P.R. et al. Magnetic resonance imaging of the caudate nuclei in depression. Preliminary observations // Arch. Gen. Psychiatry. -1992. - Vol. 49, N 7. - P. 553-557. 69. Lacerda A.L., Keshavan M.S., Hardan A.Y. et al. Anatomic evaluation of the orbitofrontal cortex in major depressive disorder // Biol. Psychiatry. - 2004. - Vol. 55, N 4. - P. 353-358. 70. Lacerda A.L., Nicoletti M.A., Brambilla P. et al. Anatomical MRI study of basal ganglia in major depressive disorder // Psychiatry Res. - 2003. - Vol. 124, N 3. - P. 129-140. 71. Ladouceur C.D., Almeida J.R., Birmaher B. et al. Subcortical gray matter volume abnormalities in healthy bipolar offspring: potential neuroanatomical risk marker for bipolar disorder? // J. Am. Acad. Child Adolecs. Psychiatry. - 2008. - Vol. 47. - P. 532-539. 72. Lagopoulos J., Ivanovski B., Malhi G.S. An event-related functional MRI study of working memory in euthymic bipolar disorder // J Psychiatry Neurosci. - 2007. - Vol. 32. - P. 174-184. 73. Lambert G., Johansson M., Agren H. et al. Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: evidence in support of the catecholamine hypothesis of mood disorders // Arch. Gen. Psychiatry. - 2000. - Vol. 57. - P. 787-793. 74. Lawrence N.S., Williams A.M., Surguladze S. et al. Subcortical and ventral prefrontal cortical neural responses to facial expressions distinguish patients with bipolar disorder and major depression // Biol. Psychiatry. - 2004. - Vol. 55. - P. 578-587. 75. Lazary J., Lazary A., Gonda X. et al. New evidence for the association of the serotonin transporter gene (SLC6A4) haplotypes, threatening life events, and depressive phenotype // Biol. Psychiatry. - 2008. - Vol. 64, N 6. - P. 498-504. 76. Lennox B.R., Jacob R., Calder A.J. et al. Behavioural and neurocognitive responses to sad facial affect are attenuated in patients with mania // Psychol. Med. - 2004. - Vol. 34. - P. 795-802. 77. Levinson D.F. The genetics of depression: a review // Biol. Psychiatry. - 2006. - Vol. 60. - P. 84-92. 78. Linke J., King A.V., Rietschel M. et al. Increased medial orbitofrontal and amygdala activation: evidence for a systems-level endophenotype of bipolar I disorder // Am. J. Psychiatry. - 2012. - Vol. 169, N 3. - P. 316-325. 79. MacMaster F.P., Mirza Y., Szeszko P.R. et al. Amygdala and hippocampal volumes in familial early onset major depressive disorder // Biol. Psychiatry. - 2008. - Vol. 63, N 4. - P. 385-390. 80. MacQueen G.M., Campbell S., McEwen B.S. et al. Course of illness, hippocampal function, and hippocampal volume in major depression // Proc. Natl Acad. Sci. USA. - 2003. - Vol. 100, N 3. - P. 1387-1392. 81. Malhi G.S., Lagopoulos J., Owen A.M. et al. Reduced activation to implicit affect induction in euthymic bipolar patients: an fMRI study // J. Affect. Disord. - 2007. - Vol. 97. - P. 109-122. 82. Manji H.K., Quiroz J.A., Sporn J. et al. Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression // Biol. Psychiatry. - 2003. - Vol. 53, N 8. - P. 707-742. 83. Marchand W.R., Lee J.N., Thatcher G.W. et al. A functional MRI study of a paced motor activation task to evaluate frontalsubcortical circuit function in bipolar depression // Psychiatry Res. - 2007. - Vol. 155. - P. 221-230. 84. Matsuo K., Kopecek M., Nicoletti M.A. et al. New structural brain imaging endophenotype in bipolar disorder // Mol. Psychiatry. - 2012. - Vol. 17, N 4. - P. 412-420. 85. Matsuo K., Walss-Bass C., Nery F.G. et al. Neuronal correlates of brain-derived neurotrophic factor Val66Met polymorphism and morphometric abnormalities in bipolar disorder // Neuropsychopharmacology. - 2009. - Vol. 34, N 8. - P. 1904-1913. 86. McKinnon M.C., Yucel K., Nazarov A., MacQueen G.M. A metaanalysis examining clinical predictors of hippocampal volume in patients with major depressive disorder // J. Psychiatry Neurosci. - 2009. - Vol. 34, N 1. - P. 41-54. 87. Mendels J., Frazer A. Brain biogenic amine depletion and mood // Arch. Gen. Psychiatry. - 1974. - Vol. 30, N 4. - P. 447-451. 88. Miller H.L., Delgado P.L., Salomon R.M. et al. Effects of alpha-methyl-para-tyrosine (AMPT) in drug-free depressed patients // Neuropsychopharmacology. - 1996. - Vol. 14. - P. 151-157. 89. Miller H.L., Delgado P.L., Salomon R.M. et al. Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression // Arch Gen Psychiatry. - 1996. - Vol. 53. - P. 117-128. 90. Molina V., Sanchez J., Sanz J. et al. Dorsolateral prefrontal N-acetyl-aspartate concentration in male patients with chronic schizophrenia and with chronic bipolar disorder // Eur. Psychiat. - 2007. - Vol. 22. - P. 505-512. 91. Moore C.M., Breeze J.L., Gruber S.A. et al. Choline, myo-inositol and mood in bipolar disorder: a proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex // Bipolar Disord. - 2000. - N 2. - P. 207-216. 92. Moore G.J., Bebchuk J.M., Wilds I.B. et al. Lithium-induced increase in human brain grey matter // Lancet. - 2000. - Vol. 356. - P. 1241-1242. 93. Murphy F.C., Smith K.A., Cowen P.J. et al. The effects of tryptophan depletion on cognitive and affective processing in healthy volunteers // Psychopharmacology. - 2002. - Vol. 163, N 1. - P. 42-53. 94. Neumeister A., Turner E.H., Matthews J.R. et al. Effects of tryptophan depletion vs catecholamine depletion in patients with seasonal affective disorder in remission with light therapy // Arch. Gen. Psychiatry. - 1998. - Vol. 55, N 6. - P. 524-530. 95. Noga J.T., Vladar K., Torrey E.F. A volumetric magnetic resonance imaging study of monozygotic twins discordant for bipolar disorder // Psychiatry Res. - 2001. - Vol. 106, N 1. - P. 25-34. 96. Patel N.C., Cerullo M.A., Fleck D.E. et al. Neuroimaging biomarkers for bipolar disorder across the lifespan // The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes / Ed. M.S. Ritsner. - 2009. - Vol. 2. - P. 171-199. 97. Peterson B.S. Conceptual, methodological, and statistical challenges in brain imaging studies of developmentally based psychopathologies // Dev. Psychopathol. - 2003. - Vol. 15. - P. 811-832. 98. Peterson B.S., Weissman M.M. A brain-based endophenotype for major depressive disorder // Annu. Rev. Med. - 2011. - Vol. 62. - P. 461-474. 99. Pezawas L., Meyer-Lindenberg A., Goldman A.L. et al. Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression // Mol. Psychiatry. - 2008. - Vol. 13, N 7. - P. 709-716. 100. Riedel W.J., Klaassen T., Schmitt J.A. Tryptophan, mood, and cognitive function // Brain. Behav. Immun. - 2002. - Vol. 16, N 5. - P. 581-589. 101. Rogers R.D., Tunbridge E.M., Bhagwagar Z. et al. Tryptophan depletion alters the decision-making of healthy volunteers through altered processing of reward cues // Neuropsychopharmacology. - 2003. - Vol. 28, N 1. - P. 153-162. 102. Rosso I.M., Killgore W.D., Cintron C.M. et al. Reduced amygdala volumes in first episode bipolar disorder and correlation with cerebral white matter // Biol. Psychiatry. - 2007. - Vol. 61. - P. 743-749. 103. Salomon R.M., Miller H.L., Krystal J.H. et al. Lack of behavioral effects of monoamine depletion in healthy subjects // Biol. Psychiatry. - 1997. - Vol. 41. - P. 58-64. 104. Sassi R.B., Nicoletti M., Brambilla P. et al. Increased gray matter volume in lithium-treated bipolar disorder patients // Neurosci. Lett. - 2002. - Vol. 329, N 2. - P. 243-245. 105. Scherk H., Backens M., Schneider-Axmann T. et al. Neurochemical pathology in hippocampus in euthymic patients with bipolar I disorder // Acta Psychiatr. Scand. - 2008. - Vol. 117. - P. 283-288. 106. Schumann C.M., Hamstra J., Goodlin-Jones B.L. et al. The amygdala is enlarged in children but not adolescents with autism; the hippocampus is enlarged at all ages // J. Neurosci. - 2004. - Vol. 24. - P. 6392-6401. 107. Sen S., Nesse R.M., Stoltenberg S.F. et al. A BDNF coding variant is associated with the NEO personality inventory domain neuroticism, a risk factor for depression // Neuropsychopharmacology. - 2003. - Vol. 28, N 2. - P. 397-401. 108. Sequeira A., Turecki G. Genome wide gene expression studies in mood disorders // OMICS. - 2006. - Vol. 10, N 4. - P. 444-454. 109. Singh M.K., Delbello M.P., Adler C.M. et al. Neuroanatomical characterization of child offspring of bipolar parents // J. Am. Acad. Child Adolecs. Psychiatry. - 2008. - Vol. 47. - P. 526-531. 110. Strakowski S.M., Adler C.M., Holland S.K. et al. A preliminary fMRI study of sustained attention in euthymic, unmedicated bipolar disorder // Neuropsychopharmacology. - 2004. - Vol. 29. - P. 1734-1740. 111. Strasser H.C., Lilyestrom J., Ashby E.R. et al. Hippocampal and ventricular volumes in psychotic and nonpsychotic bipolarpatients compared with schizophrenia patients and community control subjects: a pilot study // Biol. Psychiatry. - 2005. - Vol. 57, N 6. - P. 633-639. 112. Surtees P.G., Wainwright N.W., Willis-Owen S.A. et al. The brain-derived neurotrophic factor Val66Met polymorphism is associated with sense of coherence in a non-clinical community sample of 7335 adults // J. Psychiatry Res. - 2007. - Vol. 41, N 8. - P. 707-710. 113. Szeszko P.R., Lipsky R., Mentschel C. et al. Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation // Mol. Psychiatry. - 2005. - Vol. 10, N 7. - P. 631-636. 114. Vakili K., Pillay S.S., Lafer B. et al. Hippocampal volume in primary unipolar major depression: a magnetic resonance imaging study // Biol. Psychiatry. - 2000. - Vol. 47, N 12. - P. 1087-1090. 115. Van der Schot A.C., Vonk R., Brans R.G.H. et al. Influence of Genes and Environment on Brain Volumes in Twin Pairs Concordant and Discordant for Bipolar Disorder // Arch. Gen. Psychiatry. - 2009. - Vol. 66, N 2. - P. 142-151. 116. Videbech P., Ravnkilde B. Hippocampal volume and depression: a meta-analysis of MRI studies // Am. J. Psychiatry. - 2004. - Vol. 161, N 11. - P. 1957-1966. 117. Warner-Schmidt J.L., Duman R.S. Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment // Hippocampus. - 2006. - Vol. 16, N 3. - P. 239-249. 118. Welper H., Aller A., Guttenthaler V. et al. Serotonin transporter gene and stress reactivity in unipolar depression: Role of the HPA system as endophenotype of the SLC6A4 gene // Nervenarzt. - 2013. 119. Wichers M., Schrijvers D., Geschwind N. et al. Mechanisms of gene-environment interactions in depression: evidence that genes potentiate multiple sources of adversity // Psychol. Med. - 2009. - Vol. 39, N 7. - P. 1077-1086. 120. Wilhelm K., Mitchell P.B., Niven H. et al. Life events, first depression onset and the serotonin transporter gene // Br. J. Psychiatry. - 2006. - Vol. 188. - P. 210-215. 121. Wilke M., Kowatch R.A., DelBello M.P. et al. Voxel-based morphometry in adolescents with bipolar disorder: first results // Psychiatry Res. - 2004. - Vol. 131. - P. 57-69. 122. Winsberg M.E., Sachs N., Tate D.L. et al. Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder // Biol. Psychiatry. - 2000. - Vol. 47. - P. 475-481. 123. Yurgelun-Todd D.A., Gruber S.A., Kanayama G. et al. fMRI during affect discrimination in bipolar affective disorder // Bipolar Disord. - 2000. - N 2. - P. 237-248.
DOI: http://dx.doi.org/10.24411/1560-957X-2013-11345
Метрики статей
Metrics powered by PLOS ALM